Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP556320.RAdK-oJyru18UOjz0MzVKw4iElvUIltHocXlpQ1ro1DgI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP556320.RAdK-oJyru18UOjz0MzVKw4iElvUIltHocXlpQ1ro1DgI130_assertion type Assertion NP556320.RAdK-oJyru18UOjz0MzVKw4iElvUIltHocXlpQ1ro1DgI130_head.
- NP556320.RAdK-oJyru18UOjz0MzVKw4iElvUIltHocXlpQ1ro1DgI130_assertion wasGeneratedBy ECO_0000203 NP556320.RAdK-oJyru18UOjz0MzVKw4iElvUIltHocXlpQ1ro1DgI130_provenance.
- NP556320.RAdK-oJyru18UOjz0MzVKw4iElvUIltHocXlpQ1ro1DgI130_assertion wasDerivedFrom befree-2016 NP556320.RAdK-oJyru18UOjz0MzVKw4iElvUIltHocXlpQ1ro1DgI130_provenance.
- NP556320.RAdK-oJyru18UOjz0MzVKw4iElvUIltHocXlpQ1ro1DgI130_assertion SIO_000772 16796775 NP556320.RAdK-oJyru18UOjz0MzVKw4iElvUIltHocXlpQ1ro1DgI130_provenance.
- NP556320.RAdK-oJyru18UOjz0MzVKw4iElvUIltHocXlpQ1ro1DgI130_assertion evidence source_evidence_literature NP556320.RAdK-oJyru18UOjz0MzVKw4iElvUIltHocXlpQ1ro1DgI130_provenance.
- NP556320.RAdK-oJyru18UOjz0MzVKw4iElvUIltHocXlpQ1ro1DgI130_assertion description "[Bcl-2 has been implicated in conferring resistance to chemotherapy in non-Hodgkin's lymphoma and is therefore a candidate prognostic marker in DLBCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP556320.RAdK-oJyru18UOjz0MzVKw4iElvUIltHocXlpQ1ro1DgI130_provenance.